Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia

被引:56
|
作者
Peel, T. [1 ]
Cheng, A. C. [2 ,3 ]
Spelman, T. [4 ]
Huysmans, M. [5 ]
Spelman, D. [2 ]
机构
[1] St Vincents Hosp, Dept Infect Dis, Melbourne, Vic, Australia
[2] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia
[3] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia
[4] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia
[5] Alfred Hosp, Dept Microbiol, Melbourne, Vic, Australia
关键词
Enterococcal bacteraemia; epidemiological methods; risk factors; vancomycin resistance; BLOOD-STREAM INFECTIONS; ANTIMICROBIAL RESISTANCE; HOSPITALIZED-PATIENTS; MORTALITY; MEROPENEM; FAECIUM; EPIDEMIOLOGY; MULTICENTER; PREDICTORS; FAECALIS;
D O I
10.1111/j.1469-0691.2011.03591.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Enterococcus is an important cause of bacteraemia. Previous epidemiological studies examining risk factors for enterococcal bacteraemia have used traditional case-control study designs, which can be potentially biased. This case-case-control study examining risk factors for enterococcal bacteraemia was conducted over 10 years (January 2000 to December 2009) in a tertiary, university-affiliated hospital. There were 440 episodes of enterococcal bacteraemia, 80 of which were caused by vancomycin-resistant Enterococcus (VRE). Two multivariable models were generated, comparing VRE and vancomycin-susceptible Enterococcus (VSE) with the same control group. VRE bacteraemia was associated with central venous catheter use (OR 11.6, 95% CI 2.6-51.5), neutropenia (OR 16.9, 95% CI 2.4-120.2), and allogenic bone marrow transplantation (OR 18.0, 95% CI 2.4-133.4). In contrast, VSE bacteraemia risk factors included: age (OR 1.0, 95% CI 1.0-1.1), exposure to metronidazole (OR 8.7, 95% CI 1.7-43.5), and gastrointestinal disease (OR 6.4, 95% CI 1.2-34.5). Meropenem use decreased the risk of VSE bacteraemia (OR 0.3, 95% CI 0.1-0.9). Hypoalbuminaemia was the only factor identified in both models (VRE, OR 6.0, 95% CI 1.7-21.1; VSE, OR 3.3, 95% CI 1.4-7.7). The absence of substantial overlap of risk factors for VRE and VSE argues in favour of differences in pathogenesis. These data suggest that environmental sources are more important in VRE bacteraemia. Endogenous sources, particularly the gastrointestinal tract, play a pivotal role in VSE bacteraemia. This study highlights the importance of infection control protocols to reduce the risk of VRE bacteraemia.
引用
收藏
页码:388 / 394
页数:7
相关论文
共 50 条
  • [1] Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes
    Robert K. Pelz
    Pamela A. Lipsett
    Sandra M. Swoboda
    Marie Diener-West
    Neil R. Powe
    Roy G. Brower
    Trish M. Perl
    Janet M. Hammond
    Craig W. Hendrix
    Intensive Care Medicine, 2002, 28 : 692 - 697
  • [2] Vancomycin-resistant and vancomycin-sensitive enterococcal bacteremia: Effect on patient outcomes.
    Wittbrodt, ET
    Cawley, MJ
    Eapen, T
    CRITICAL CARE MEDICINE, 1999, 27 (01) : A86 - A86
  • [3] Vancomycin-resistant enterococcal infections: Cause for concern? Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: Attributable costs and outcomes.
    Snydman, DR
    LIVER TRANSPLANTATION, 2003, 9 (11) : 1227 - 1228
  • [4] Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes
    Pelz, RK
    Lipsett, PA
    Swoboda, SM
    Diener-West, M
    Powe, NR
    Brower, RG
    Perl, TM
    Hammond, JM
    Hendrix, CW
    INTENSIVE CARE MEDICINE, 2002, 28 (06) : 692 - 697
  • [5] Risk Factors and Outcomes of Vancomycin-Resistant Versus Vancomycin-Sensitive Enterococcal Bloodstream Infections in Patients With Acute Myeloid Leukemia
    Hackney, Noah
    Addisu, Anteneh
    Nanjappa, Sowmya
    Greene, John
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2019, 27 (02) : 85 - 89
  • [6] Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
    Mave, Vidya
    Garcia-Diaz, Julia
    Islam, Tareq
    Hasbun, Rodrigo
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (01) : 175 - 180
  • [7] Molecular characterization of virulence genes in vancomycin-resistant and vancomycin-sensitive enterococci
    Biswas, Priyanka Paul
    Dey, Sangeeta
    Sen, Aninda
    Adhikari, Luna
    JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2016, 8 (01) : 16 - 24
  • [8] Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
    King, Esther A.
    McCoy, Dorothy
    Desai, Samit
    Nyirenda, Themba
    Bicking, Keri
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (09) : 2112 - 2118
  • [9] Vancomycin-resistant enterococcal endophthalmitis
    Huang, E
    Chu, T
    Chaum, E
    Mukai, S
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [10] Vancomycin-Resistant Enterococcal Endophthalmitis
    Sharma, Shobha
    Desai, Rajen U.
    Pass, Adam B.
    Saffra, Norman A.
    ARCHIVES OF OPHTHALMOLOGY, 2010, 128 (06) : 794 - 795